Oturum Aç

Skeletal muscle relaxants can target the central nervous system [CNS]to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.

Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs, such as baclofen, diazepam, and tizanidine, primarily act on the CNS. Most of these drugs are administered orally, although some may be given intramuscularly or intravenously. The duration of action of these drugs typically ranges from 5 to 24 hours. Spasmolytic drugs are commonly used to manage severe and chronic spasms caused by conditions such as multiple sclerosis, cerebral palsy, stroke, spinal cord injuries, and muscle injuries. However, they may have side effects such as sedation, weakness, hypotension, and the potential for rebound spasticity upon discontinuing the medication. Antispasmodics have a shorter duration of action, typically lasting from 4 to 6 hours. They can produce strong antimuscarinic effects such as constipation, bradycardia, and urinary retention. An example of an antispasmodic drug is cyclobenzaprine, which is primarily given orally to treat acute spasms resulting from muscle injuries.

Peripherally acting drugs are also classified into neuromuscular blockers and directly acting agents. Succinylcholine, d-tubocurarine, cisatracurium, and rocuronium are some examples of neuromuscular blockers. These drugs are often administered intravenously. Their duration of action ranges from 5 to 60 minutes. These are given along with anesthetics to prolong muscle relaxation during surgeries. They can cause side effects like hypotension, prolonged apnea, intraocular pressure, and postoperative muscle pain. Dantrolene and botulinum toxin are examples of directly acting relaxants that are administered intramuscularly or orally. Duration of action ranges from 4 hours to 2 months. These medications weaken muscle contraction, leading to flaccid paralysis, and effectively treat spasms caused by conditions such as cerebral palsy, multiple sclerosis, and overactive bladder

Etiketler

Muscle RelaxantsCentrally ActingPeripherally ActingSpasmolytic DrugsAntispasmodic DrugsNeuromuscular BlockersMuscle Tension ReductionBaclofenDiazepamTizanidineCyclobenzaprineSuccinylcholineDantroleneBotulinum ToxinSide EffectsDuration Of Action

Bölümden 7:

article

Now Playing

7.12 : Peripherally and Centrally Acting Muscle Relaxants: A Comparison

İskelet Kası Gevşeticileri

3.0K Görüntüleme Sayısı

article

7.1 : Nöromüsküler Kavşak Ve Blokaj

İskelet Kası Gevşeticileri

2.7K Görüntüleme Sayısı

article

7.2 : İskelet Kası Gevşeticilerinin Sınıflandırılması

İskelet Kası Gevşeticileri

2.3K Görüntüleme Sayısı

article

7.3 : Nondepolarizan (Rekabetçi) Nöromüsküler Blokerler: Etki Mekanizması

İskelet Kası Gevşeticileri

1.2K Görüntüleme Sayısı

article

7.4 : Nondepolarizan (Rekabetçi) Nöromusküler Blokerler: Farmakolojik Etkiler

İskelet Kası Gevşeticileri

346 Görüntüleme Sayısı

article

7.5 : Nondepolarizan (Rekabetçi) Nöromusküler Blokerler: Farmakokinetik

İskelet Kası Gevşeticileri

408 Görüntüleme Sayısı

article

7.6 : Depolarize Edici Blokerler: Etki Mekanizması

İskelet Kası Gevşeticileri

1.0K Görüntüleme Sayısı

article

7.7 : Depolarizan Blokerler: Pharmokokinetiği

İskelet Kası Gevşeticileri

280 Görüntüleme Sayısı

article

7.8 : Doğrudan etkili kas gevşeticiler: Dantrolene ve botulinum toksini

İskelet Kası Gevşeticileri

600 Görüntüleme Sayısı

article

7.9 : İskelet Kası Gevşeticiler: Yan Etkiler

İskelet Kası Gevşeticileri

307 Görüntüleme Sayısı

article

7.10 : İskelet Kası Gevşeticiler: Terapötik Kullanımlar

İskelet Kası Gevşeticileri

432 Görüntüleme Sayısı

article

7.11 : Spazmolitik Ajanlar: Kimyasal Sınıflandırma

İskelet Kası Gevşeticileri

828 Görüntüleme Sayısı

article

7.13 : Merkezi Etkili Kas Gevşeticiler: Terapötik Kullanımlar

İskelet Kası Gevşeticileri

562 Görüntüleme Sayısı

JoVE Logo

Gizlilik

Kullanım Şartları

İlkeler

Araştırma

Eğitim

JoVE Hakkında

Telif Hakkı © 2020 MyJove Corporation. Tüm hakları saklıdır